Effect of intermittent irradiation and fluence-response of 222 nm ultraviolet light on SARS-CoV-2 contamination.


Journal

Photodiagnosis and photodynamic therapy
ISSN: 1873-1597
Titre abrégé: Photodiagnosis Photodyn Ther
Pays: Netherlands
ID NLM: 101226123

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 26 11 2020
revised: 01 01 2021
accepted: 08 01 2021
pubmed: 24 1 2021
medline: 7 4 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

The effectiveness of 222 nm ultraviolet (UV) C light for disinfecting surfaces contaminated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported. The aim of this study was to evaluate the effect of the intermittent irradiation of 222 nm UVC on SARS-CoV-2 and the fluence-dependent effect of 222 nm UVC irradiation on SARS-CoV-2 inactivation. We experimented with 5 min continuous and intermittent irradiation for 0.1, 0.05, 0.013, and 0.003 mW/cm At each irradiance, no significant difference was observed in the log reduction of SARS-CoV-2 between continuous and intermittent irradiation. At each UV fluence, no significant difference was observed in the log reduction of SARS-CoV-2 among the three different irradiance levels. There was no significant difference between continuous and intermittent irradiation with 222 nm UVC with regards to SARS-CoV-2 inactivation. Moreover, 222 nm UVC inactivates SARS-CoV-2 in a fluence-dependent manner. The efficacy of 222-nm UVC irradiation in reducing the contamination of SARS-CoV-2 needs to be further evaluated in a real-world setting.

Sections du résumé

BACKGROUND BACKGROUND
The effectiveness of 222 nm ultraviolet (UV) C light for disinfecting surfaces contaminated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported. The aim of this study was to evaluate the effect of the intermittent irradiation of 222 nm UVC on SARS-CoV-2 and the fluence-dependent effect of 222 nm UVC irradiation on SARS-CoV-2 inactivation.
METHODS METHODS
We experimented with 5 min continuous and intermittent irradiation for 0.1, 0.05, 0.013, and 0.003 mW/cm
RESULTS RESULTS
At each irradiance, no significant difference was observed in the log reduction of SARS-CoV-2 between continuous and intermittent irradiation. At each UV fluence, no significant difference was observed in the log reduction of SARS-CoV-2 among the three different irradiance levels.
CONCLUSION CONCLUSIONS
There was no significant difference between continuous and intermittent irradiation with 222 nm UVC with regards to SARS-CoV-2 inactivation. Moreover, 222 nm UVC inactivates SARS-CoV-2 in a fluence-dependent manner. The efficacy of 222-nm UVC irradiation in reducing the contamination of SARS-CoV-2 needs to be further evaluated in a real-world setting.

Identifiants

pubmed: 33484873
pii: S1572-1000(21)00010-7
doi: 10.1016/j.pdpdt.2021.102184
pmc: PMC7817413
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102184

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Références

Water Res. 2015 Mar 1;70:27-37
pubmed: 25506761
Int J Infect Dis. 2020 Nov;100:224-229
pubmed: 32891736
Water Res. 2014 May 15;55:143-9
pubmed: 24607520
Photochem Photobiol Sci. 2002 Apr;1(4):225-36
pubmed: 12661961
Am J Infect Control. 2020 Oct;48(10):1273-1275
pubmed: 32763344
Am J Infect Control. 2021 Jun;49(6):800-803
pubmed: 33186680
Am J Infect Control. 2021 Mar;49(3):299-301
pubmed: 32896604
Emerg Microbes Infect. 2020 Dec;9(1):1744-1747
pubmed: 32673522
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
Virol J. 2020 Oct 7;17(1):145
pubmed: 33028356

Auteurs

Hiroki Kitagawa (H)

Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan; Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan; Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Toshihito Nomura (T)

Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan; Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Tanuza Nazmul (T)

Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Reo Kawano (R)

Clinical Research Center in Hiroshima, Hiroshima University Hospital, Hiroshima, Japan.

Keitaro Omori (K)

Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan.

Norifumi Shigemoto (N)

Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan; Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan; Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Translational Research Center, Hiroshima University, Hiroshima, Japan.

Takemasa Sakaguchi (T)

Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Hiroki Ohge (H)

Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan; Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH